Incidence of Colorectal Cancer in Southwest China: Based on SCC Database

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06172049

Enrollment

5838

Registered

2023-12-15

Start date

2014-01-01

Completion date

2023-10-31

Last updated

2023-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

To evaluate recent trends in CRC incidence, treatment, and survival in the Southwest China.

Detailed description

The epidemiological feature of colorectal cancer (CRC) showed different trends among countries. Studying the epidemiological and management characteristics between China and the US has important implications for understanding the current status of cancer occurrence, treatment and survival. we established the Southwest China Colorectal (SCC) database, aiming to provide reference information on the diagnosis and management of CRC in China.

Interventions

OTHERtreatment

the actual treatment CRC patients have reveived

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Clinical diagnosis of colorectal cancer; 2. Received treatment in medical institutions; 3. Regular follow-up after the diagnosis.

Exclusion criteria

Patients who lost to follow-up

Design outcomes

Primary

Measure	Time frame	Description
Survival	From inclusion until date of death from any cause, or untile the 2023-10-31	Overall survival (OS) untile the end of follow up

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026